US3146163A - Apparatus for separating certain components from blood - Google Patents

Apparatus for separating certain components from blood Download PDF

Info

Publication number
US3146163A
US3146163A US168165A US16816562A US3146163A US 3146163 A US3146163 A US 3146163A US 168165 A US168165 A US 168165A US 16816562 A US16816562 A US 16816562A US 3146163 A US3146163 A US 3146163A
Authority
US
United States
Prior art keywords
blood
recess portion
components
principal
slide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
US168165A
Inventor
John H Brewer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to US168165A priority Critical patent/US3146163A/en
Application granted granted Critical
Publication of US3146163A publication Critical patent/US3146163A/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Images

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/15Devices for taking samples of blood
    • A61B5/150007Details
    • A61B5/150015Source of blood
    • A61B5/150022Source of blood for capillary blood or interstitial fluid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/15Devices for taking samples of blood
    • A61B5/150007Details
    • A61B5/150206Construction or design features not otherwise provided for; manufacturing or production; packages; sterilisation of piercing element, piercing device or sampling device
    • A61B5/150305Packages specially adapted for piercing devices or blood sampling devices
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/15Devices for taking samples of blood
    • A61B5/150007Details
    • A61B5/150374Details of piercing elements or protective means for preventing accidental injuries by such piercing elements
    • A61B5/150381Design of piercing elements
    • A61B5/150412Pointed piercing elements, e.g. needles, lancets for piercing the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/15Devices for taking samples of blood
    • A61B5/151Devices specially adapted for taking samples of capillary blood, e.g. by lancets, needles or blades
    • A61B5/15101Details
    • A61B5/15103Piercing procedure
    • A61B5/15105Purely manual piercing, i.e. the user pierces the skin without the assistance of any driving means or driving devices
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/15Devices for taking samples of blood
    • A61B5/151Devices specially adapted for taking samples of capillary blood, e.g. by lancets, needles or blades
    • A61B5/15142Devices intended for single use, i.e. disposable
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/483Physical analysis of biological material
    • G01N33/487Physical analysis of biological material of liquid biological material
    • G01N33/49Blood
    • G01N33/491Blood by separating the blood components
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/15Devices for taking samples of blood
    • A61B5/150007Details
    • A61B5/150343Collection vessels for collecting blood samples from the skin surface, e.g. test tubes, cuvettes
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/805Test papers
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/81Packaged device or kit

Definitions

  • FIG. 5 APPARATUS FOR SEPARATING CERTAIN COMPONENTS FROM BLOOD 2 Sheets-Sheet 2 Filed Jan. 25, 1962 FIG. 5
  • This invention relates to an improved apparatus and method for separating liquid containing components such as plasma and serum from other components in a small sample of blood.
  • a further object is the provision of an improved apparatus and method of the above character in which the apparatus is small and compact and is relatively inexpensive and disposable thereby eliminating the problems of contamination and sterilization.
  • My invention contemplates the provision of a relatively thin compact member such as a slide having an upper surface formed with a recess having a liquid impervious surface depressed below the surface of the card.
  • the recess has a relatively larger principal recess portion for initially receiving the blood sample and it also has a relatively smaller auxiliary recess portion communicating with the principal recess portion.
  • the principal recess portion contains an agent preferably in the form of a coating which includes a hemagglutinin for causing certain of the components such as the blood cells to separate from the remainder of the blood.
  • the blood sample is placed in the principal recess portion and is stirred around therein to cause the blood to thoroughly mix with the hemagglutinin until the said components including the blood cells separate from the remainder of the blood and precipitate in the principal recess portion. Thereafter, the card is tilted to cause the liquid containing components of the blood to flow into the auxiliary recess portion while the separated components remain in the principal recess portion.
  • the serum or plasma thus collected in the auxiliary recess portion can be used at once or can be dried and thereafter reconstituted to be used for making the desired immunological, serological or chemical tests or reactions.
  • FIG. 1 is a perspective view of apparatus in the form of a slide embodying my invention to be used in separating the liquid containing components from a small sample of blood;
  • FIG. 2 is a fragmentary cross-sectional view in the direction of the arrows on the line 2 -2 of FIG. 1;
  • FIG. 3 is a perspective view illustrating my apparatus in horizontal position overlapping the edge of a supporting surface and serving to illustrate the first and second steps of my method;
  • FIG. 4 is a similiar perspective view showing my ap paratus tilted at an angle on the same supporting surface and serving to illustrate the third step of my method;
  • FIG. 5 is a top plan view of a kit serving as a commercial package for my apparatus and showing the envelope of the kit in sealed condition;
  • FIG. 6 is an exploded view of the kit showing the envelope broken open and revealing the contents thereof including my improved apparatus and other auxiliary equipment which may be conveniently used therewith.
  • my improved apparatus comprises a relatively compact, thin, flat member 10, preferably in the form of a slide or card having a relatively flat upper surface 11 with a recess 12 formed therein.
  • the recess has a liquid impervious surface depressed below the upper surface 11 of the card.
  • the recess is provided with a relatively larger principal recess portion 13 disposed nearer to one end of the card and also with a relatively smaller auxiliary recess portion 14 communicating therewith and disposed nearer to the opposite end of the card.
  • the slide is made either of a suitable material which is itself inert to the blood components and is impervious to the liquid components of blood or it is made of any other suitable material having applied thereto or at least to the recess 12 a surface or coating which is inert to the blood components and impervious to the liquid components of blood.
  • the slide may be made of a suitable plastic such as polypropylene, polyethylene, polystyrene or a polyvinyl plastic having a plasticizer which is inert to the blood components.
  • the slide is made of a suitable fiberboard such as paperboard or newsprint board having a sizing such as a casein sizing.
  • Either the entire upper surface or at least the recess portion thereof has applied thereto a coating inert to the blood components and impervious to the liquid components of blood such as polyethylene, polypropylene, polystyrene or a polyvinyl plastic of the type indicated.
  • the recess 12 is of sufficient depth to confine the initial blood sample within the principal recess portion 13 when the slide is in horizontal position and to confine the liquid containing components thereof within the auxiliary recess portion when the slide is tilted at an angle as hereinafter described.
  • the area of the principal recess portion is sufficiently large so that the cohesion of the blood will confine the initial blood sample within the principal portion without flowing into the auxiliary portion when the card is disposed in horizontal position.
  • the area of the auxiliary recess portion is sufficiently large to hold the liquid containing components of the blood when the card or slide is tilted at an angle as hereinafter described.
  • the present apparatus is intended for use with relatively small blood samples such as are obtained by puncturing a finger or an ear lobe with a lancet. For this purpose, two to five drops of blood generally serve quite satisfactorily. I have found that in using my ap- J paratus in connection with small samples of approximately this size satisfactory results are obtained if the recess is at least approximately 0.1 mm. in depth and if the area of the principal recess portion is at least approximately 300 mm. and if the area of the auxiliary recess portion is at least approximately 75 mm?.
  • the initial blood sample of two to five drops, preferably approximately three drops, is placed in the principal recess portion 13 and in the principal recess portion certain of the components are caused to separate as by agglutination, coagulation or precipitation.
  • I provide agents within the principal recess portion for causing the separation, agglutination, clotting or precipitation of certain of the components. These agents are preferably applied in the form of a coating to the surface of the principal recess portion 13.
  • the coating should include a suitable homagglutinin such as phytohemagglutinin or that produced by immunological procedures. Where it is desired to collect serum, then the coating should also preferably include a suitable coagulant or clotting agent to accelerate the clotting of the fibrinogen, such as thrombin, or this may be accomplished more slowly by rapid stirring.
  • the coating should in clude in addition to the hemagglutinin a suitable anticoagulant or anti-clotting agent such as heparin, dicou marol, sodium citrate, potassium oxalate, ammonium oxalate, lithium oxalate, sodium oxalate or ethylenediaminitetraacetate.
  • a suitable anticoagulant or anti-clotting agent such as heparin, dicou marol, sodium citrate, potassium oxalate, ammonium oxalate, lithium oxalate, sodium oxalate or ethylenediaminitetraacetate.
  • hemagglutinin I prefer to employ a substantially pure phytohemagglutinin, such as those made from the seeds of the Leguminosae.
  • a very satisfactory phytohemagglutinin is the one obtained from kidney beans.
  • a hemagglutinin which causes the precipitation of the globulin fraction should not be used.
  • I have found that satisfactory results are obtained by using at least approximately 0.3 mg., preferably 0.5 mg., in the coating in the principal recess portion.
  • the coating may be applied by mixing approximately 0.5 mg. of phytohemagglutinin in 0.1 ml. of physiological saline and then spreading it evenly over the surface of the principal recess portion and permitting it to dry.
  • heparin In the collection of plasma, as the anti-clotting agent or anticoagulant I prefer to employ heparin for use with a blood sample of the size indicated. In a recess of the indicated size I have found that satisfactory results are obtained if I use at least approximately 0.02 mg., preferably approximately 0.1 mg, of heparin in the coating.
  • the heparin may be mixed with the physiological saline along with the phytohemagglutinin and applied to the surface of the principal recess portion.
  • thrombin as the coagulating or clotting agent. I have found that satisfactory results are obtained by using at least 10 units, preferably 12 units, in the coating. The units indicated are N.I.H. units established by the National Institute of Health.
  • the thrombin may be mixed along with the phytohemagglutinin in the physiological saline and applied to the surface of the principal recess portion.
  • Slides of the type indicated may be packaged in sterile form in sealed containers or envelopes of the type indicated in FIGS. and 6.
  • the envelope is inert and impervious to the coating materials employed in the recess 12 and is also impervious to microorganisms and contaminants. It may be made of any desired inert and impervious sheet materials.
  • the envelope 20 is formed of two sheets of metal foil, preferably of aluminum foil, having a thermoplastic lining such as a lining of polyethylene, polypropylene or polyvinylchloride.
  • the card or slide 10 is placed between the two sheets of metal foil with the thermoplastic lining arranged in confronting relationship and the envelope is then heat sealed around the edges thereof as indicated at 21. In order to obtain access to the slide and remove it from the package, it is simply necessary to tear or sever the envelope to expose the contents as indicated in FIG. 6.
  • the package is preferably prepared in the form of a complete kit and it contains the additional equipment required for using the slide in collecting a small blood sample and separating the serum or plasma therefrom.
  • the envelope contains a small disposable lancet 22, a stirring rod which may be similar to a toothpick indicated at 23 and a wire loop shown at 24. Instead of a wire loop, a capillary or pipette or other device for removing liquid may be supplied. All of this equipment is packaged within the envelope in sterile form.
  • the lancet may be separately packaged within the envelope in a smaller sealed envelope 25 which may be similar to the envelope 20. It will be appreciated that the inner envelope 25 is torn or severed so as to expose the lancet 22.
  • the entire kit is of compact form being no more than approximately three inches by six inches in size and with the slide being no larger than approximately two inches by 5 inches.
  • a number of the kits can be readily transported by a physician or a serologist for the purpose of conducting immunological, serological and chemical blood tests and reactions in the oflice or in the field. No other facilities, such as glassware, laboratory equipment or centrifuges, are necessary in order to collect the small blood sample and separate the serum or plasma therefrom.
  • Example 1 Prepare the coating by mixing together the following ingredients:
  • the slide may then be packaged along with a suitable lancet, preferably of the disposable type, a suitable stirring rod and a loop or pipette in a sealed envelope, thereby providing a slide ready for use in collecting a small blood sample and separating plasma therefrom.
  • Example II Prepare the coating by mixing together the following ingredients:
  • Example I The materials are mixed together and applied to the surface of the principal recess and thereafter the slide is packaged as in Example I.
  • Example Ill The quantity of coating materials indicated in Examples I and II are entirely satisfactory for testing blood from human beings and most laboratory animals. However, in the case of bovine or cows blood a much greater quantity is required. The following example is particularly suitable for testing of bovine blood.
  • Example I After the materials are mixedtogether, the coating material is applied and the slide is packaged as in Example I. However, in using the slide one additional drop of saline is added to the principal recess at the time the blood is added.
  • Example IV The following materials are mixed together:
  • the slide thus prepared may be packaged in a sealed envelope along with a lancet, preferably of the disposable type, a stirring rod and a loop or pipette, thereby providing a kit suitable for use in collecting blood and in separating serum therefrom.
  • Example V The following materials are mixed together:
  • Example IV After the materials are thus mixed together, they are applied to the surface of the principal recess and the slide is packaged as indicated in Example IV. However, in using this slide the blood sample should be stirred more rapidly and for a more prolonged period of time (one or two minutes) to cause the clotting of the fibrinogen since no clotting agent is present in the coating material.
  • the envelope is first opened so as to expose the contents thereof.
  • the disposable lancet is then used for the purpose of puncturing a finger or the ear lobe and a small sample of blood from two to five drops, preferably three drops, is collected in the principal recess portion 13 of the slide 10.
  • the slide is then placed on a horizontal surface such as the top 26 of table 27.
  • the stirring rod or toothpick 23 is then used for stirring the blood sarnple around the entire principal portion 13 of the recess causing it to mix thoroughly with the hemagglutinin in the coating.
  • the stirring continues for about 30 to 50 seconds.
  • the slide should be tilted and rotated to cause the blood to distribute the cells evenly and allow the plasma or serum to begin separation. However, as indicated above, care should be taken to avoid permitting any of the blood to flow into the auxiliary recess portion.
  • the blood during the stirring operation also mixes with the anticoagulant or anti-clotting agent, thereby preventing the fibrinogen from clotting.
  • the blood mixes with the coaguluant or clotting agent, thereby hastening the clotting of the fibrinogen.
  • the hemagglutinin causes the blood cells to agglutinate and to precipitate in the principal recess portion. If the slide were prepared for the collection of serum, then the fibrinogen also clots and precipitates during this period in the principal recess portion. Thereafter, the slide is shifted to the edge of the table or supporting surface so that the tab 17 overlaps the edge with the fold line 16 in registry therewith, as indicated in FIG. 3. The fold down tab 17 is then folded downwardly at right angles to the major portion of the slide, the slide is then shifted backwardly to be fully disposed on the table top as shown in FIG. 4 with the result the it is supported in a tilted position.
  • liquid containing components of the blood i.e., the plasma or serum
  • the liquid containing components of the blood i.e., the plasma or serum
  • any desired amount thereof can be removed, as by means of a pipette or capillary or by means of the loop 24 for purposes of conducting the desired immunological, serological or chemical tests or reactions.
  • the liquid containing component of the blood can be dried in the auxiliary recess portion and then be reconstituted and tested at a later date.
  • the specific length of the fold down tab 17 and the angle at which the slide is supported when the tab is folded downwardly may be varied. I have found that in a slide of the type illustrated and described with a recess of the indicated size for collecting a small blood sample satisfactory results are obtained if the slide is supported at an angle of approximately five to twenty degress, preferably ten to fifteen degrees.
  • a device for use in separating liquid containing components from other components in a small blood sample which comprises a relatively thin flat slide presenting an upper surface formed with a recess having a liquid impervious surface depressed below the level of said upper surface and formed with a principal recess portion for initially receiving the blood sample and containing a coating including a hemagglutinin for causing certain of the components including the blood cells to precipitate in said principal recess portion and also formed with an auxiliary recess portion communicating with the principal recess portion for thereafter receiving the unprecipitated and liquid components of the blood.
  • a device for use in separating liquid containing components from other components in a small blood sample of approximately 2 to 5 drops which comprises a relatively thin fiat slide presenting an upper surface formed with a recess having a liquid impervious surface depressed below the level of said upper surface at least approximately 0.1 mm.
  • auxiliary recess portion communicating with the principal recess portion for thereafter receiving the unseparated and liquid compo- 8 nents ofthe blood, said auxiliary recess portion being at least large enough to accommodate the unseparated and liquid components of the blood sample.

Description

Aug. 25, 1964 J. H. BREWER APPARATUS FOR SEPARATING CERTAIN COMPONENTS FROM BLOOD 2 Sheets-Sheet 1 Filed Jan. 23, 1962 k RM 2 W Aug. 25, 1964 J. H. BREWER 3,146,163
APPARATUS FOR SEPARATING CERTAIN COMPONENTS FROM BLOOD 2 Sheets-Sheet 2 Filed Jan. 25, 1962 FIG. 5
FIG. 6
INVENTOR. .rmw xx B/P'h EF United States Patent Office 3,145,163 Patented Aug. 25, 1964 3,146,163 APPARATUS F913 SEPARATHNG CERTAIN CDMPUNENTS FRGM BLOOD John H. Brewer, 4-25 Oak Lane, Towson 4, Mid. Filed Jan. 23, 1962, Ser. No. 168,165 8 Claims. (Cl. 167-74) This invention relates to an improved apparatus and method for separating liquid containing components such as plasma and serum from other components in a small sample of blood.
It is a particular object of the present invention to provide a practical, rapid, simple and inexpensive device and method for use in separating plasma and serum from small samples of blood such as can be obtained from finger punctures.
Most immunological, serological and chemical tests and reactions performed with blood require the use of plasma or serum. Heretofore, this has generally been obtained from the arm vein and the cells are separated from the serum or plasma by centrifuging. With the improvement of micro-chemical techniques, many of these tests can be performed with very small samples of blood obtained from puncturing the finger or ear lobe. This has generally been accomplished by means of a lancet which is used to draw two or three drops of blood from which a usable amount of serum or plasma may be collected. The separation of the serum or plasma from the small samples of blood has generally been accomplished by causing the blood to flow into a capillary tube and then centrifuging the blood in the capillary tube to separate the blood cells from the liquid containing components thereof. In both of these procedures the centrifuging is time consuming and, in addition, requires special centrifuging equipment, electric current and other laboratory facilities.
It is an object of the present invention to overcome the difliculties and disadvantages heretofore encountered and to provide an improved apparatus and method for separating the liquid containing components such as plasma and serum from a small blood sample and which is simple to use, which requires a minimum amount of time and which does not require the use of centrifuging apparatus or laboratory equipment.
A further object is the provision of an improved apparatus and method of the above character in which the apparatus is small and compact and is relatively inexpensive and disposable thereby eliminating the problems of contamination and sterilization.
My invention contemplates the provision of a relatively thin compact member such as a slide having an upper surface formed with a recess having a liquid impervious surface depressed below the surface of the card. The recess has a relatively larger principal recess portion for initially receiving the blood sample and it also has a relatively smaller auxiliary recess portion communicating with the principal recess portion. The principal recess portion contains an agent preferably in the form of a coating which includes a hemagglutinin for causing certain of the components such as the blood cells to separate from the remainder of the blood. The blood sample is placed in the principal recess portion and is stirred around therein to cause the blood to thoroughly mix with the hemagglutinin until the said components including the blood cells separate from the remainder of the blood and precipitate in the principal recess portion. Thereafter, the card is tilted to cause the liquid containing components of the blood to flow into the auxiliary recess portion while the separated components remain in the principal recess portion. The serum or plasma thus collected in the auxiliary recess portion can be used at once or can be dried and thereafter reconstituted to be used for making the desired immunological, serological or chemical tests or reactions.
In the accompanying drawing:
FIG. 1 is a perspective view of apparatus in the form of a slide embodying my invention to be used in separating the liquid containing components from a small sample of blood;
FIG. 2 is a fragmentary cross-sectional view in the direction of the arrows on the line 2 -2 of FIG. 1;
FIG. 3 is a perspective view illustrating my apparatus in horizontal position overlapping the edge of a supporting surface and serving to illustrate the first and second steps of my method;
FIG. 4 is a similiar perspective view showing my ap paratus tilted at an angle on the same supporting surface and serving to illustrate the third step of my method;
FIG. 5 is a top plan view of a kit serving as a commercial package for my apparatus and showing the envelope of the kit in sealed condition; and
FIG. 6 is an exploded view of the kit showing the envelope broken open and revealing the contents thereof including my improved apparatus and other auxiliary equipment which may be conveniently used therewith.
Referring to the drawings, and more particularly to FIGS. 1 and 2 thereof, my improved apparatus comprises a relatively compact, thin, flat member 10, preferably in the form of a slide or card having a relatively flat upper surface 11 with a recess 12 formed therein.
The recess has a liquid impervious surface depressed below the upper surface 11 of the card. The recess is provided with a relatively larger principal recess portion 13 disposed nearer to one end of the card and also with a relatively smaller auxiliary recess portion 14 communicating therewith and disposed nearer to the opposite end of the card.
The slide is made either of a suitable material which is itself inert to the blood components and is impervious to the liquid components of blood or it is made of any other suitable material having applied thereto or at least to the recess 12 a surface or coating which is inert to the blood components and impervious to the liquid components of blood. Thus, the slide may be made of a suitable plastic such as polypropylene, polyethylene, polystyrene or a polyvinyl plastic having a plasticizer which is inert to the blood components. Preferably, however, the slide is made of a suitable fiberboard such as paperboard or newsprint board having a sizing such as a casein sizing. Either the entire upper surface or at least the recess portion thereof has applied thereto a coating inert to the blood components and impervious to the liquid components of blood such as polyethylene, polypropylene, polystyrene or a polyvinyl plastic of the type indicated.
The recess 12 is of sufficient depth to confine the initial blood sample within the principal recess portion 13 when the slide is in horizontal position and to confine the liquid containing components thereof within the auxiliary recess portion when the slide is tilted at an angle as hereinafter described.
The area of the principal recess portion is sufficiently large so that the cohesion of the blood will confine the initial blood sample within the principal portion without flowing into the auxiliary portion when the card is disposed in horizontal position. The area of the auxiliary recess portion is sufficiently large to hold the liquid containing components of the blood when the card or slide is tilted at an angle as hereinafter described.
The present apparatus is intended for use with relatively small blood samples such as are obtained by puncturing a finger or an ear lobe with a lancet. For this purpose, two to five drops of blood generally serve quite satisfactorily. I have found that in using my ap- J paratus in connection with small samples of approximately this size satisfactory results are obtained if the recess is at least approximately 0.1 mm. in depth and if the area of the principal recess portion is at least approximately 300 mm. and if the area of the auxiliary recess portion is at least approximately 75 mm?.
The initial blood sample of two to five drops, preferably approximately three drops, is placed in the principal recess portion 13 and in the principal recess portion certain of the components are caused to separate as by agglutination, coagulation or precipitation. For this purpose, I provide agents within the principal recess portion for causing the separation, agglutination, clotting or precipitation of certain of the components. These agents are preferably applied in the form of a coating to the surface of the principal recess portion 13.
For certain purposes it is desirable to collect serum which consists of the liquid containing components of blood free of the cells and fibrinogen. For other purposes, it is desirable to collect plasma which consists of the liquid containing components free of the cells but including the fibrinogen. In the collection of either serum or plasma the coating should include a suitable homagglutinin such as phytohemagglutinin or that produced by immunological procedures. Where it is desired to collect serum, then the coating should also preferably include a suitable coagulant or clotting agent to accelerate the clotting of the fibrinogen, such as thrombin, or this may be accomplished more slowly by rapid stirring. Where it is desired to collect plasma, then the coating should in clude in addition to the hemagglutinin a suitable anticoagulant or anti-clotting agent such as heparin, dicou marol, sodium citrate, potassium oxalate, ammonium oxalate, lithium oxalate, sodium oxalate or ethylenediaminitetraacetate.
As the hemagglutinin, I prefer to employ a substantially pure phytohemagglutinin, such as those made from the seeds of the Leguminosae. A very satisfactory phytohemagglutinin is the one obtained from kidney beans. A hemagglutinin which causes the precipitation of the globulin fraction should not be used. For a recess of the size indicated for use with a small blood sample of the size indicated, i.e., between two and five drops, I have found that satisfactory results are obtained by using at least approximately 0.3 mg., preferably 0.5 mg., in the coating in the principal recess portion. The coating may be applied by mixing approximately 0.5 mg. of phytohemagglutinin in 0.1 ml. of physiological saline and then spreading it evenly over the surface of the principal recess portion and permitting it to dry.
In the collection of plasma, as the anti-clotting agent or anticoagulant I prefer to employ heparin for use with a blood sample of the size indicated. In a recess of the indicated size I have found that satisfactory results are obtained if I use at least approximately 0.02 mg., preferably approximately 0.1 mg, of heparin in the coating. The heparin may be mixed with the physiological saline along with the phytohemagglutinin and applied to the surface of the principal recess portion.
Where my apparatus is used in collecting serum, I prefer to employ thrombin as the coagulating or clotting agent. I have found that satisfactory results are obtained by using at least 10 units, preferably 12 units, in the coating. The units indicated are N.I.H. units established by the National Institute of Health. The thrombin may be mixed along with the phytohemagglutinin in the physiological saline and applied to the surface of the principal recess portion.
Slides of the type indicated may be packaged in sterile form in sealed containers or envelopes of the type indicated in FIGS. and 6. The envelope is inert and impervious to the coating materials employed in the recess 12 and is also impervious to microorganisms and contaminants. It may be made of any desired inert and impervious sheet materials. Thus, in the illustrated embodiment the envelope 20 is formed of two sheets of metal foil, preferably of aluminum foil, having a thermoplastic lining such as a lining of polyethylene, polypropylene or polyvinylchloride. The card or slide 10 is placed between the two sheets of metal foil with the thermoplastic lining arranged in confronting relationship and the envelope is then heat sealed around the edges thereof as indicated at 21. In order to obtain access to the slide and remove it from the package, it is simply necessary to tear or sever the envelope to expose the contents as indicated in FIG. 6.
The package is preferably prepared in the form of a complete kit and it contains the additional equipment required for using the slide in collecting a small blood sample and separating the serum or plasma therefrom. Thus, as indicated in FIG. 6, the envelope contains a small disposable lancet 22, a stirring rod which may be similar to a toothpick indicated at 23 and a wire loop shown at 24. Instead of a wire loop, a capillary or pipette or other device for removing liquid may be supplied. All of this equipment is packaged within the envelope in sterile form. The lancet may be separately packaged within the envelope in a smaller sealed envelope 25 which may be similar to the envelope 20. It will be appreciated that the inner envelope 25 is torn or severed so as to expose the lancet 22.
It will be seen that the entire kit is of compact form being no more than approximately three inches by six inches in size and with the slide being no larger than approximately two inches by 5 inches. Thus, a number of the kits can be readily transported by a physician or a serologist for the purpose of conducting immunological, serological and chemical blood tests and reactions in the oflice or in the field. No other facilities, such as glassware, laboratory equipment or centrifuges, are necessary in order to collect the small blood sample and separate the serum or plasma therefrom.
The following examples give representative coating procedures and coatings to be used in preparing the slides for the collection of blood and the separation of plasma.
Example 1 Prepare the coating by mixing together the following ingredients:
Substantially pure phytohemagglutinin mg 0.5 Heparin mg 0.1 Physiological saline rnl 0.1
After the materials have been thoroughly mixed to gether, spread the mixture evenly over the surface of the principal recess portion and then permit the coating to dry, leaving a mixture of the phytohemagglutinin, the heparin and the salts uniformly distributed over the principal recess portion. The slide may then be packaged along with a suitable lancet, preferably of the disposable type, a suitable stirring rod and a loop or pipette in a sealed envelope, thereby providing a slide ready for use in collecting a small blood sample and separating plasma therefrom.
Example II Prepare the coating by mixing together the following ingredients:
Hemagglutinin -mg 0.5 Sodium citrate mg 1.0 Norman saline ml 0.1
The materials are mixed together and applied to the surface of the principal recess and thereafter the slide is packaged as in Example I.
Example Ill The quantity of coating materials indicated in Examples I and II are entirely satisfactory for testing blood from human beings and most laboratory animals. However, in the case of bovine or cows blood a much greater quantity is required. The following example is particularly suitable for testing of bovine blood.
Prepare the coating by mixing together the following:
Hemagglutinin mg 3.0 Heparin mg 0.2 Normal saline ml 0.1
After the materials are mixedtogether, the coating material is applied and the slide is packaged as in Example I. However, in using the slide one additional drop of saline is added to the principal recess at the time the blood is added.
The following examples give representative coating procedures and coatings to be applied to the recesses in the slides for use in collecting small blood samples and separating serum therefrom.
Example IV The following materials are mixed together:
Substantially pure phytohemagglutinin 0.5 mg.
Thombin N.I.H.
units.
Physiological saline 0.1 ml.
After the materials are thoroughly mixed together, the mixture is spread evenly over the principal recess portion of the slide and the permitted to dry, leaving a coating of uniformly mixed phytohemagglutinin, alum and salts. The slide thus prepared may be packaged in a sealed envelope along with a lancet, preferably of the disposable type, a stirring rod and a loop or pipette, thereby providing a kit suitable for use in collecting blood and in separating serum therefrom.
Example V The following materials are mixed together:
Hemagglutinin mg 0.5 Normal saline ml 0.1
After the materials are thus mixed together, they are applied to the surface of the principal recess and the slide is packaged as indicated in Example IV. However, in using this slide the blood sample should be stirred more rapidly and for a more prolonged period of time (one or two minutes) to cause the clotting of the fibrinogen since no clotting agent is present in the coating material.
It should be understood that the other hemagglutinins, clotting agents and anticoagulants listed in this specification may be substituted for the specific materials listed in Examples I-V. It should also be understood that where larger blood samples are treated and larger recesses are provided that the quantity of the coating materials should be increased proportionately.
In using my improved apparatus, the envelope is first opened so as to expose the contents thereof. The disposable lancet is then used for the purpose of puncturing a finger or the ear lobe and a small sample of blood from two to five drops, preferably three drops, is collected in the principal recess portion 13 of the slide 10. The slide is then placed on a horizontal surface such as the top 26 of table 27. The stirring rod or toothpick 23 is then used for stirring the blood sarnple around the entire principal portion 13 of the recess causing it to mix thoroughly with the hemagglutinin in the coating. In this connection, care should be taken to avoid stirring the blood into the auxiliary recess portion 14. The stirring continues for about 30 to 50 seconds. During the stirring, the slide should be tilted and rotated to cause the blood to distribute the cells evenly and allow the plasma or serum to begin separation. However, as indicated above, care should be taken to avoid permitting any of the blood to flow into the auxiliary recess portion.
Where the slide is prepared for the collection of plasma, the blood during the stirring operation also mixes with the anticoagulant or anti-clotting agent, thereby preventing the fibrinogen from clotting. On the other hand,
where the slide is prepared for the collection of serum, the blood mixes with the coaguluant or clotting agent, thereby hastening the clotting of the fibrinogen.
During the stirring operation, the hemagglutinin causes the blood cells to agglutinate and to precipitate in the principal recess portion. If the slide were prepared for the collection of serum, then the fibrinogen also clots and precipitates during this period in the principal recess portion. Thereafter, the slide is shifted to the edge of the table or supporting surface so that the tab 17 overlaps the edge with the fold line 16 in registry therewith, as indicated in FIG. 3. The fold down tab 17 is then folded downwardly at right angles to the major portion of the slide, the slide is then shifted backwardly to be fully disposed on the table top as shown in FIG. 4 with the result the it is supported in a tilted position. The liquid containing components of the blood, i.e., the plasma or serum, will then flow downwardly from the principal portion of the recess into the auxiliary portion thereof. When all of the serum or plasma have thus been collected in the auxiliary portion of the recess, any desired amount thereof can be removed, as by means of a pipette or capillary or by means of the loop 24 for purposes of conducting the desired immunological, serological or chemical tests or reactions.
Instead of being used at once, the liquid containing component of the blood can be dried in the auxiliary recess portion and then be reconstituted and tested at a later date.
The specific length of the fold down tab 17 and the angle at which the slide is supported when the tab is folded downwardly may be varied. I have found that in a slide of the type illustrated and described with a recess of the indicated size for collecting a small blood sample satisfactory results are obtained if the slide is supported at an angle of approximately five to twenty degress, preferably ten to fifteen degrees.
It will thus been seen that I have provided an improved apparatus and method for use in separating liquid containing components from other components in a small sample of blood. My method and apparatus have the advantage that it is not necessary that they be used in the laboratory as they can be conveniently transported and used either in an ofiice or in the field. They have the further advantage that serum and plasma may be readily separated from small samples of blood without the use of centrifuges or other laboratory equipment.
It should be understood that modifications may be made in the illustrated and described embodiment of my invention without departing from the invention as set forth in the accompanying claims.
I claim:
1. A device for use in separating liquid containing components from other components in a small blood sample which comprises a relatively thin flat slide presenting an upper surface formed with a recess having a liquid impervious surface depressed below the level of said upper surface and formed with a principal recess portion for initially receiving the blood sample and containing a coating including a hemagglutinin for causing certain of the components including the blood cells to precipitate in said principal recess portion and also formed with an auxiliary recess portion communicating with the principal recess portion for thereafter receiving the unprecipitated and liquid components of the blood.
2. A device for use in separating liquid containing components from other components in a small blood sample as set forth in claim 1 in which the coating in the principal recess portion also includes an anti-clotting agent to prevent the fibrinogen from clotting so that plasma is collected in the auxillary recess portion.
3. A device for use in separating liquid containing components from other components in a small blood sample as set forth in claim 1 in which the coating in the principal recess portion also includes a coagulant to accelerate clotting of the fibrinogen so that serum is collected in the auxiliary recess portion.
4. A device for use in separating liquid containing components from other components in a small blood sample as set forth in claim 1 in which the principal recess portion is sufiiciently large so that the blood sample is retained therein by its cohesion.
5. A device for use in separating liquid containing components from other components in a small blood sample as set forth in claim 1 in which the hemagglutinin is a phytohemagglutinin.
6. A device for use in separating liquid containing components from other components in a small blood sample of approximately 2 to 5 drops which comprises a relatively thin fiat slide presenting an upper surface formed with a recess having a liquid impervious surface depressed below the level of said upper surface at least approximately 0.1 mm. and formed with a principal recess portion for initially receiving the blood sample and large enough so that the blood is retained therein by its own cohesion and containing a coating including a hemagglutinin for causing certain of the components including the blood cells to separate in said principal recess portion and also formed with an auxiliary recess portion communicating with the principal recess portion for thereafter receiving the unseparated and liquid compo- 8 nents ofthe blood, said auxiliary recess portion being at least large enough to accommodate the unseparated and liquid components of the blood sample.
7. A device for use in separating liquid containing components from other components in a small blood sample of approximately 2 to 5 drop as set forth in claim 6 in which the coating also includes an anticlotting agent for the fibrinogen.
8. A device for use in separating liquid containing components from other components in a small blood sample of approximately 2 to 5 drops as set forth in claim 6 in which the principal recess portion has an area of at least approximately 300 mm. and the auxiliary recess portion has an area of at least approximately mm.
References Cited in the file of this patent UNITED STATES PATENTS 2,561,339 Chediak July 24, 1951 FOREIGN PATENTS 989,480 France May 23, 1951 OTHER REFERENCES Eimer and Amend: Chemical and Physical Apparatus, Catalog, pp. 380, New York, 1903, QD/53/E34. (Copy in Group (86).

Claims (1)

1. A DEVICE FOR USE IN SEPARATING LIQUID CONTAINING COMPONENTS FROM OTHER COMPONENTS IN A SMALL BLOOD SAMPLE WHICH COMPRISES A RELATIVELY THIN FLAT SLIDE PRESENTING AN UPPER SURFACE FORMED WITH A RECESS HAVING A LIQUID IMPERVIOUS SURFACE DEPRESSED BELOW THE LEVEL OF SAID UPPER SURFACE AND FORMED WITH A PRINCIPAL RECESS PORTION FOR INITIALLY RECEIVING THE BLOOD SAMPLE AND CONTAINING A COATING INCLUDING A HEMAGGLUTININ FOR CAUSING CERTAIN OF THE COMPONENTS INCLUDING THE BLOOD CELLS TO PRECIPITATE IN SAID PRINCIPAL RECESS PORTION AND ALSO FORMED WITH AN AUXILIARY RECESS PORTION COMMUNICATING WITH THE PRINCIPAL RECESS PORTION FOR THEREAFTER RECEIVING THE UNPRECIPITATED AND LIQUID COMPONENTS OF THE BLOOD.
US168165A 1962-01-23 1962-01-23 Apparatus for separating certain components from blood Expired - Lifetime US3146163A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US168165A US3146163A (en) 1962-01-23 1962-01-23 Apparatus for separating certain components from blood

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US168165A US3146163A (en) 1962-01-23 1962-01-23 Apparatus for separating certain components from blood
DEB0072273 1963-06-14
FR940286A FR1361738A (en) 1963-06-14 1963-07-03 Method and device for separating certain elements from blood

Publications (1)

Publication Number Publication Date
US3146163A true US3146163A (en) 1964-08-25

Family

ID=46640136

Family Applications (1)

Application Number Title Priority Date Filing Date
US168165A Expired - Lifetime US3146163A (en) 1962-01-23 1962-01-23 Apparatus for separating certain components from blood

Country Status (5)

Country Link
US (1) US3146163A (en)
CH (1) CH412405A (en)
DE (1) DE1498577B2 (en)
FR (1) FR1361738A (en)
GB (1) GB969741A (en)

Cited By (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3449083A (en) * 1966-02-10 1969-06-10 Applied Science Lab Inc Descending thin layer chromatography apparatus
US3650698A (en) * 1969-12-04 1972-03-21 Technicon Corp Apparatus for the automatic determination of the coagulation, aggregation and or flocculation, or the like, rates of fluids, and novel reaction intensifying agent for use therewith
US3853468A (en) * 1972-05-08 1974-12-10 H Haymond Method and apparatus for clinical testing of biological fluids
US3898982A (en) * 1972-11-13 1975-08-12 Jintan Terumo Co Capillary tube for blood examination
US3965888A (en) * 1975-02-12 1976-06-29 Brenner And Bender, Inc. Specimen collector and holder
US3978846A (en) * 1975-01-02 1976-09-07 Bailey Donald L Syringe for taking blood samples
US4180060A (en) * 1972-08-18 1979-12-25 Boehringer Mannheim Gmbh Device for staining biological materials
US4250257A (en) * 1978-08-24 1981-02-10 Technicon Instruments Corporation Whole blood analyses in porous media
US4260392A (en) * 1978-07-07 1981-04-07 Technicon Instruments Corporation Method and apparatus for obtaining an aliquot of a liquid in a gel medium
US4288228A (en) * 1979-01-31 1981-09-08 Technicon Instruments Corporation Whole blood analyses and diffusion apparatus therefor
WO1983000877A1 (en) * 1981-08-31 1983-03-17 Icl Scient Glucose oxidase immunohistochemical detection of antinuclear antibodies
EP0225703A2 (en) * 1985-11-01 1987-06-16 Becton Dickinson and Company Method of improving the demarcation and separation of cells in centrifuged blood samples
US4678757A (en) * 1985-04-11 1987-07-07 Smithkline Diagnostics, Inc. Device and method for whole blood separation and analysis
US5252293A (en) * 1989-01-17 1993-10-12 Vladimir Drbal Analytical slide with porous filter membrane
US5262067A (en) * 1990-05-15 1993-11-16 Boehringer Mannheim Gmbh Device and its use for the separation of plasma from whole blood
US5460974A (en) * 1992-10-13 1995-10-24 Miles Inc. Method of assaying whole blood for HDL cholesterol
US5650332A (en) * 1995-11-14 1997-07-22 Coulter International Corp. Method for the preparation of microscope slides
US5665238A (en) * 1994-05-19 1997-09-09 The United States Of America As Represented By The Administrator Of The National Aeronautics And Space Administration Method and apparatus for the collection storage and real time analysis of blood and other bodily fluids
US20050106552A1 (en) * 2002-02-27 2005-05-19 Eiji Ikeda Instrument for separating plasma or serum, method of collecting plasma or serum, method of separating plasma or serum, test carrier and glass fiber
US20210205524A1 (en) * 2019-04-27 2021-07-08 Lansion Biotechnology Co., Ltd Method for whole blood filtration and filter membrane structure for whole blood filtration

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3902964A (en) * 1971-12-13 1975-09-02 U S Medical Research And Dev I Method of and apparatus for chemically separating plasma or serum from formed elements of blood
NL8401536A (en) * 1984-05-11 1985-12-02 Medscan B V I O BLOOD SAMPLING UNIT.
DE3441149A1 (en) * 1984-11-10 1986-05-15 Merck Patent Gmbh, 6100 Darmstadt METHOD FOR SEVERAL BLOOD SEPARATION
FI940823A0 (en) * 1994-02-22 1994-02-22 Orion Yhtymae Oy Analyzer cuvette Foer turbidimetric and nephelometric test of the helix

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2561339A (en) * 1944-01-10 1951-07-24 Chediak Alejandro Apparatus for laboratory investigations
FR989480A (en) * 1949-06-23 1951-09-10 F A T Device for the analysis of arable land and other applications

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2561339A (en) * 1944-01-10 1951-07-24 Chediak Alejandro Apparatus for laboratory investigations
FR989480A (en) * 1949-06-23 1951-09-10 F A T Device for the analysis of arable land and other applications

Cited By (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3449083A (en) * 1966-02-10 1969-06-10 Applied Science Lab Inc Descending thin layer chromatography apparatus
US3650698A (en) * 1969-12-04 1972-03-21 Technicon Corp Apparatus for the automatic determination of the coagulation, aggregation and or flocculation, or the like, rates of fluids, and novel reaction intensifying agent for use therewith
US3853468A (en) * 1972-05-08 1974-12-10 H Haymond Method and apparatus for clinical testing of biological fluids
US4180060A (en) * 1972-08-18 1979-12-25 Boehringer Mannheim Gmbh Device for staining biological materials
US3898982A (en) * 1972-11-13 1975-08-12 Jintan Terumo Co Capillary tube for blood examination
US3978846A (en) * 1975-01-02 1976-09-07 Bailey Donald L Syringe for taking blood samples
US3965888A (en) * 1975-02-12 1976-06-29 Brenner And Bender, Inc. Specimen collector and holder
US4260392A (en) * 1978-07-07 1981-04-07 Technicon Instruments Corporation Method and apparatus for obtaining an aliquot of a liquid in a gel medium
US4250257A (en) * 1978-08-24 1981-02-10 Technicon Instruments Corporation Whole blood analyses in porous media
US4288228A (en) * 1979-01-31 1981-09-08 Technicon Instruments Corporation Whole blood analyses and diffusion apparatus therefor
WO1983000877A1 (en) * 1981-08-31 1983-03-17 Icl Scient Glucose oxidase immunohistochemical detection of antinuclear antibodies
US4678757A (en) * 1985-04-11 1987-07-07 Smithkline Diagnostics, Inc. Device and method for whole blood separation and analysis
EP0225703A2 (en) * 1985-11-01 1987-06-16 Becton Dickinson and Company Method of improving the demarcation and separation of cells in centrifuged blood samples
EP0225703A3 (en) * 1985-11-01 1987-07-22 Wardlaw, Stephen Clark Method of improving the demarcation and separation of cells in centrifuged blood samples
US5252293A (en) * 1989-01-17 1993-10-12 Vladimir Drbal Analytical slide with porous filter membrane
US5529752A (en) * 1989-01-17 1996-06-25 Molecular Devices Corporation Analytical work station
US5262067A (en) * 1990-05-15 1993-11-16 Boehringer Mannheim Gmbh Device and its use for the separation of plasma from whole blood
US5460974A (en) * 1992-10-13 1995-10-24 Miles Inc. Method of assaying whole blood for HDL cholesterol
US5665238A (en) * 1994-05-19 1997-09-09 The United States Of America As Represented By The Administrator Of The National Aeronautics And Space Administration Method and apparatus for the collection storage and real time analysis of blood and other bodily fluids
US5650332A (en) * 1995-11-14 1997-07-22 Coulter International Corp. Method for the preparation of microscope slides
US20050106552A1 (en) * 2002-02-27 2005-05-19 Eiji Ikeda Instrument for separating plasma or serum, method of collecting plasma or serum, method of separating plasma or serum, test carrier and glass fiber
US7407742B2 (en) 2002-02-27 2008-08-05 Sanko Junyaku Co., Ltd. Plasma or serum separator, plasma or serum sampling method, plasma or serum separating method, test carrier and glass fiber
US20210205524A1 (en) * 2019-04-27 2021-07-08 Lansion Biotechnology Co., Ltd Method for whole blood filtration and filter membrane structure for whole blood filtration

Also Published As

Publication number Publication date
DE1498577A1 (en) 1969-04-30
CH412405A (en) 1966-04-30
FR1361738A (en) 1964-05-22
GB969741A (en) 1964-09-16
DE1498577B2 (en) 1970-12-03

Similar Documents

Publication Publication Date Title
US3146163A (en) Apparatus for separating certain components from blood
US20230243809A1 (en) Device for whole blood separation
CN104582571B (en) Device for quick testing and method
US7153477B2 (en) Device and method for separating components of a fluid sample
US4769333A (en) Personal diagnostic kit
US4698311A (en) Particle washing and separation method
US20010008614A1 (en) Sample collection system and method of use thereof
US4859603A (en) Personal diagnostic kit
DE69731439T2 (en) COMBINED REAGENT AND TEST ARRANGEMENT
US3272319A (en) Immunological test kit
JP2000502451A (en) Diagnostic analysis leading to plasma separation
JP3325620B2 (en) Method of performing density gradient centrifugation and the insert for stratification used for it
IT1284550B1 (en) PROCEDURE FOR THE PREPARATION OF AUTOLOGOUS FIBRIN GLUE FOR SURGICAL USE
Noguchi Serum diagnosis of syphilis and luetin reaction
DE3609980A1 (en) METHOD FOR DETERMINING HAEMOGLOBIN IN THE CHAIR
WO1994018892A1 (en) Device for the processing of saliva for use in an immunoassay
DE2541031A1 (en) Prepackaged antigens and antibodies - in stable freeze dried form on a carrier enclosed in a vacuum sealed foil
JPH05505962A (en) Blood bag used to separate blood components
US2342409A (en) Diagnostic reagent and process
Wiener et al. Group-Specific Substances in the Saliva of the New-Born
Sekiguchi et al. A new type of blood component collector: plasma separation using gravity without any electrical devices
Blakeslee et al. The J substance of cattle
DE3725504C2 (en)
Denborough et al. Serum blood group substances and ABO haemolytic disease
RU2129281C1 (en) Identification strips for express-test for individual compatibility of donor and recipient blood